Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Severe and Refractory Polyarteritis Nodosa Associated With CECR1 Mutation and Dramatic Response to Infliximab in Adulthood.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases - 1 Apr 2020

Teixeira Vítor, Oliveira-Ramos Filipa, Costa Manuela

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Deaminase
Share to Antirheumatic Agents
Share to Aspirin
Share to Infliximab

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intercellular Signaling Peptides and Proteins

Share to Lysine

Share to Mutation

Share to Prednisolone

Source

Identifiers

PMID: 29916967
DOI: 10.1097/RHU.0000000000000839

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Severe and Refractory Polyarteritis Nodosa Associated With CECR1 Mutation and Dramatic Response to Infliximab in Adulthood.PMID 29916967Read ↗

Prevalence of CECR1 mutations in pediatric patients with polyarteritis nodosa, livedo reticularis and/or strokeSemantic proximity Read ↗

Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation.Semantic proximity Read ↗

Novel compound heterozygous variants in CECR1 gene associated with childhood onset polyarteritis nodosa and deficiency of ADA2.Semantic proximity Read ↗

Update on CECR1 molecular diagnostics: new mutations in the deficiency of ADA2 (DADA2) and the North American polyarteritis nodosa (PAN) cohortSemantic proximity Read ↗

A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts.Semantic proximity Read ↗

Polyarteritis Nodosa Reviewed in 2023: Old Disease, New EtiologiesSemantic proximity Read ↗

Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy.Semantic proximity Read ↗

Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.Semantic proximity Read ↗

Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.Semantic proximity Read ↗

Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.Semantic proximity Read ↗

Polyarteritis nodosa revisited: a review of historical approaches, subphenotypes and a research agenda.Semantic proximity Read ↗

Case Report: Deficiency in Adenosine Deaminase 2 mimicking a childhood Polyarteritis Nodosa: A case report of two siblings with a novel mutationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.